Theratechnologies Inc T.TH

New Press Release - Theratechnologies Provides Update on EGRIFTA SV® Supply

MONTREAL, Jan. 09, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced that a shortage of EGRIFTA SV® (tesamorelin for...read article.

[palinc2000]

Shhhhhhhhhhhhhhhhhhhhhhh

[Trogarzon]

There goes our CEO confidence in avoiding a shortage...lol

[Trogarzon]

Help me out here .... the FDA will answer the companies questions no later than Feb. 8... is that the PSA answer or what... that would mean only like 3 weeks of shortage... but again it's NOT CLEAR.... 

[Trogarzon]

I looks like the answer as to when they can expect to have a answer for the new batch approval.... basically if it will be faster than 4 months or April 18 at worse.

[Trogarzon]

If its a whole Q1 without Egrifta well it's on them for not keeping a safe level of inventory and on the BOD for not being diligent.

[Trogarzon]

Maybe we go up tomorrow.. to bad they could'nt put a cancer deal on the table before this turd had to come out.... expected has usual... they always deliver on the bad news front.. that they can do.... 

[Trogarzon]

So if we don't loose the last 50 cents of gains of late tomorrow it's good news... otherwise they just manage to scrap the last couple of announcements in a flash.  Again....

[Trogarzon]

Maybe this temporary f..up motivates a buyer to take this off our hands on the cheap..... instead of making a partnership.

[muslix1]

today we go back 2,50$ cnd... no chance

[Trogarzon]

I take everything at face value with them.. bad is bad... might be a month before we know the date of the end of this shortage wich could be a whole quarter away.  The hope of a deal is still there and we were told that we ad a expert in the art of the deal when our savior arrived. But if the past is a testament of the future well... let the facts speak.

[PWIB123]

US Markets were closed yesterday, but THTX took a big hit on the TSX before recovering mostly yesterday.  Who knew that report was going to get released before it did?  Looked like insider trading violations to me.  No way that was a coincidence.  But, alas, the THTX curse strikes again, and our very expensive leader, Paul, once again misses the mark and ends up being wrong

[Trogarzon]

They are shortsighted like always been... the former CEO and production guy used to insist on 1 to 2 years of inventory.... it's just not well managed company when you complie all those misteps... expensive dilutions and lots of wasted money... our money...

[Trogarzon]

And yes it's all about cancer now and the lined up partners waiting for data to make a deal according to the super one overthere don't seem to be in a hurry....

[Maxmoe]

Or....you could have sold some. I know a guy that sold some close to 52w high. Heck, nobody's perfect. He missed the top. But he's not buying back any more until the boo birds are horse voiced from the gloating. Shouldn't take too long but 35 cents is just a minor correction. He took 100% of his investment $$ off the table when the stock doubled and now still has a fair position. Or so

[palinc2000]

It seems almost surreal that they have recently restarted production and manufactured 3 batches ( and maybe more ) taking into consideration the observations from an inspection in September by FDA related solely to the manufacturing environment of the facility Why would FDA allow patients to run out of the only approved drug for Lipodistrophy? Something does NOT make sense !!!! In the

[Trogarzon]

Is there a a chance the Type D meeting response from FDA before Feb. 8 results in a stamp of approval for the newly manufactured Egrifta batches.  That would limit the damage.